Novanta (NASDAQ:NOVT) CEO Matthijs Glastra Sells 6,500 Shares of Stock

Novanta Inc. (NASDAQ:NOVT) CEO Matthijs Glastra sold 6,500 shares of the stock in a transaction dated Friday, April 17th. The stock was sold at an average price of $130.05, for a total transaction of $845,325.00. Following the completion of the transaction, the chief executive officer directly owned 56,761 shares of the company’s stock, valued at approximately $7,381,768.05. The trade was a 10.27% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Matthijs Glastra also recently made the following trade(s):

• On Tuesday, February 10th, Matthijs Glastra sold 7,500 shares of Novanta stock. The stock was sold at an average price of $145.04, for a total transaction of $1,087,800.00.
• On Wednesday, January 21st, Matthijs Glastra sold 7,500 shares of Novanta stock. The stock was sold at an average price of $140.00, for a total transaction of $1,050,000.00.

Novanta Price Performance

NOVT stock opened at $132.40 on Wednesday. Novanta Inc. has a 1 year low of $98.27 and a 1 year high of $149.95. The company has a market cap of $4.72 billion, a P/E ratio of 90.68 and a beta of 1.64. The firm has a 50-day moving average of $128.14 and a 200 day moving average of $123.07. The company has a debt-to-equity ratio of 0.16, a current ratio of 3.69 and a quick ratio of 2.80.

Novanta (NASDAQ:NOVT) last released its quarterly earnings results on Monday, February 23rd. The technology company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.88 by $0.03. Novanta had a net margin of 5.49% and a return on equity of 13.12%. The company had revenue of $258.35 million during the quarter, compared to the consensus estimate of $260.72 million. During the same period in the prior year, the firm earned $0.76 earnings per share. Novanta has set its FY 2026 guidance at 3.500-3.650 EPS and its Q1 2026 guidance at 0.750-0.800 EPS. On average, sell-side analysts forecast that Novanta Inc. will post 3.54 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on the stock. Weiss Ratings reissued a “hold (c-)” rating on shares of Novanta in a research note on Friday. Wall Street Zen downgraded shares of Novanta from a “buy” rating to a “hold” rating in a research note on Saturday. Zacks Research upgraded shares of Novanta from a “strong sell” rating to a “hold” rating in a report on Friday, January 16th. Finally, Robert W. Baird upgraded shares of Novanta from a “neutral” rating to an “outperform” rating and cut their price objective for the stock from $150.00 to $144.00 in a report on Monday, March 30th. One analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $144.00.

Institutional Investors Weigh In On Novanta

A number of hedge funds and other institutional investors have recently bought and sold shares of NOVT. Pilgrim Partners Asia Pte Ltd purchased a new stake in Novanta in the third quarter worth about $36,000. Migdal Insurance & Financial Holdings Ltd. purchased a new stake in Novanta in the third quarter worth about $40,000. Danske Bank A S purchased a new stake in Novanta in the third quarter worth about $40,000. Allworth Financial LP grew its holdings in Novanta by 978.4% in the fourth quarter. Allworth Financial LP now owns 399 shares of the technology company’s stock worth $47,000 after purchasing an additional 362 shares during the period. Finally, EverSource Wealth Advisors LLC grew its holdings in Novanta by 120.1% in the fourth quarter. EverSource Wealth Advisors LLC now owns 427 shares of the technology company’s stock worth $51,000 after purchasing an additional 233 shares during the period. Hedge funds and other institutional investors own 98.35% of the company’s stock.

About Novanta

Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.

Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.